Osteopore Limited (ASX:OSX)
0.0090
-0.0010 (-10.00%)
Feb 11, 2026, 4:10 PM AEST
Osteopore Revenue
Osteopore had revenue of 1.56M AUD in the half year ending June 30, 2025, with 56.34% growth. This brings the company's revenue in the last twelve months to 2.85M, up 5.52% year-over-year. In the year 2024, Osteopore had annual revenue of 2.76M with 24.60% growth.
Revenue (ttm)
2.85M
Revenue Growth
+5.52%
P/S Ratio
1.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.76M | 545.37K | 24.60% |
| Dec 31, 2023 | 2.22M | 525.02K | 31.02% |
| Dec 31, 2022 | 1.69M | 579.38K | 52.06% |
| Dec 31, 2021 | 1.11M | -391.57K | -26.03% |
| Dec 31, 2020 | 1.50M | 1.09M | 265.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Pro Medicus | 212.98M |
| Freedom Care Group Holdings | 32.54M |
| Elixinol Wellness | 15.85M |
| Genetic Technologies | 9.17M |
| Global Health | 8.67M |